サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1446561

BGMデバイス（血糖測定器）の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント別予測、2024年～2030年

Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Self-Monitoring Devices, Continuous Glucose Monitoring Devices), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.46円
BGMデバイス（血糖測定器）の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年02月29日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

BGMデバイス（血糖測定器）市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、BGMデバイスの世界市場規模は2030年までに232億1,000万米ドルに達する見込みです。

同市場は2024年から2030年にかけてCAGR 8.25％で拡大すると予測されています。糖尿病患者とその医療専門家は、BGMデバイスから大きな利益を得ています。BGMデバイスは、集中的な糖尿病治療の重要な要素として広く受け入れられるようになってきています。これにより、糖尿病患者はどこにいても、簡単かつ便利に数分以内に血糖値を測定することができます。持続的血糖モニタリング（CGM）デバイスは、血糖値を連続的かつリアルタイムで分析するのに役立ちます。また、患者が食事の摂取量やインスリンの投与量を決定するのにも役立ちます。さらに、ジャンクフード、アルコール、喫煙の摂取を含む座りがちなライフスタイルや、より安全で迅速な診断に対するニーズの急増といった要因が、予測期間中の市場成長を押し上げると予想されます。

国際糖尿病連合（IDF）によると、糖尿病患者の総数は2030年までに6億4,300万人（11.3％）、2045年までに7億8,300万人（12.2％）に拡大すると予想されています。肥満は、糖尿病有病率を押し上げる大きな要因のひとつです。肥満の人が糖尿病を発症する可能性は、肥満でない人の最大80倍です。研究によると、18歳以上の6億5,000万人が肥満です。さらに、糖尿病をコントロールするための政府や国際糖尿病連合（IDF）などのヘルスケア組織による継続的な取り組みにより、予測期間を通じて市場は急速なペースで上昇する可能性が高いです。利害関係者や協力者のネットワークを通じて、これらの組織は必要な専門知識を提供し、糖尿病啓発キャンペーンを支援しています。また、医療費の増加も市場の成長を後押しすると予想されます。

BGMデバイス市場レポートハイライト

  • 有利な償還政策、主要企業の現地進出、政府の支援策により、北米が2023年に最大の売上シェアを占めました。
  • 製品別では、セルフモニタリングデバイスが2023年に66.37%の最大収益シェアを占め、予測期間中に大きな成長が見込まれます。
  • CBGMデバイスの製品セグメントは、予測期間中に最も急成長するセグメントとなる見込みです。
  • セルフモニタリングデバイスでは、検査ストリップの使用率が高く、価格も手ごろであることから、2023年には検査ストリップ部門が最大の収益シェアを占めました。
  • 最終用途別では、在宅ケア分野が予測期間中に急成長する見込みです。

目次

第1章 調査手法と範囲

第2章 BGMデバイス市場：エグゼクティブサマリー

  • 市場スナップショット
  • 製品と最終用途のスナップショット
  • 競合情勢のスナップショット

第3章 BGMデバイス市場：変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
  • 市場促進要因分析
    • 世界中で高齢者人口が増加
    • 糖尿病患者の増加
    • 糖尿病予防ケアに対する意識の向上
  • 市場抑制要因分析
    • デバイスのコストが高い
  • BGMデバイス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析
    • 価格分析

第4章 BGMデバイス：製品の推定・動向分析

  • 世界のBGMデバイス市場：製品セグメントダッシュボード
  • 製品別の世界のBGMデバイス市場の見通し
  • 世界のBGMデバイス市場規模と動向分析、製品別、2018年から2030年
  • セルフモニタリングデバイス
  • CBGMデバイス

第5章 BGMデバイス：最終用途の推定・動向分析

  • 世界のBGMデバイス市場：最終用途セグメントダッシュボード
  • 最終用途別の世界のBGMデバイス市場の見通し
  • 世界のBGMデバイス市場規模と動向分析、最終用途別、2018年から2030年
  • 病院
  • 在宅ケア
  • 診断センター

第6章 地域のビジネス分析

  • 地域の市場ダッシュボード
  • 世界の地域の市場スナップショット
  • 市場規模と予測動向分析、2018年から2030年まで
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • タイ
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業別の最近の動向と影響分析
  • 会社/競合の分類
  • ベンダー情勢
    • Abbott
    • Medtronic plc
    • F. Hoffmann-La Roche Ltd
    • Ascensia Diabetes Care Holdings AG
    • LifeScan IP Holdings, LLC
    • Dexcom, Inc
    • SANOFI
    • Lilly（Elly Lilly and Company）
    • B Braun SE
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Blood Glucose Monitoring Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 3 North America Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 North America Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 5 U.S. Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 U.S. Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7 Canada Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 Canada Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9 Europe Blood Glucose Monitoring Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 10 Europe Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 Europe Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 UK Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 UK Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 14 Germany Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Germany Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16 France Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 France Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 Italy Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Italy Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20 Spain Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Spain Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22 Sweden Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Sweden Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24 Norway Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Norway Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26 Denmark Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Denmark Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Blood Glucose Monitoring Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 31 Japan Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Japan Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 33 China Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 China Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35 India Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 India Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Australia Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 38 Australia Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39 South Korea Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 South Korea Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41 Thailand Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 Thailand Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Latin America Blood Glucose Monitoring Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 44 Latin America Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 45 Latin America Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Brazil Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Brazil Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48 Mexico Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 49 Mexico Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50 Argentina Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Argentina Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 MEA Blood Glucose Monitoring Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 53 MEA Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 MEA Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 55 South Africa Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 South Africa Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 UAE Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 UAE Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews in North America
  • Fig. 5 Primary Interviews in Europe
  • Fig. 6 Primary Interviews In APAC
  • Fig. 7 Primary Interviews in Latin America
  • Fig. 8 Primary Interviews In MEA
  • Fig. 9 Market Research Approaches
  • Fig. 10 Value-Chain-Based Sizing & Forecasting
  • Fig. 11 QFD Modeling for Market Share Assessment
  • Fig. 12 Market Formulation & Validation
  • Fig. 13 Blood Glucose Monitoring Devices Market: Market Outlook
  • Fig. 14 Blood Glucose Monitoring Devices Competitive Insights
  • Fig. 15 Parent Market Outlook
  • Fig. 16 Related/Ancillary Market Outlook
  • Fig. 17 Penetration and Growth Prospect Mapping
  • Fig. 18 Industry Value Chain Analysis
  • Fig. 19 Blood Glucose Monitoring Devices Market Driver Impact
  • Fig. 20 Blood Glucose Monitoring Devices Market Restraint Impact
  • Fig. 21 Blood Glucose Monitoring Devices Market Strategic Initiatives Analysis
  • Fig. 22 Blood Glucose Monitoring Devices Market: Product Movement Analysis
  • Fig. 23 Blood Glucose Monitoring Devices Market: Product Outlook and Key Takeaways
  • Fig. 24 Self-Monitoring Devices Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 Blood Glucose Meter Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Strips Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Lancets Market Estimates and Forecast, 2018 - 2030
  • Fig. 28 Continuous monitoring devices Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Sensor Market Estimates and Forecast, 2018 - 2030
  • Fig. 30 Transmitter and Receiver Market Estimates and Forecast, 2018 - 2030
  • Fig. 31 Insulin pumps Market Estimates and Forecast, 2018 - 2030
  • Fig. 32 Blood Glucose Monitoring Devices Market: End Use Movement Analysis
  • Fig. 33 Blood Glucose Monitoring Devices Market: End Use Outlook and Key Takeaways
  • Fig. 34 Hospitals Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Home Care Market Estimates and Forecasts, 2018 - 2030
  • Fig. 36 Diagnostic Centers Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 Global Blood Glucose Monitoring Devices Market: Regional Movement Analysis
  • Fig. 38 Global Blood Glucose Monitoring Devices Market: Regional Outlook and Key Takeaways
  • Fig. 39 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 65 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 Kuwait Market Estimates and Forecasts, 2018 - 2030
  • Fig. 67 Market Categorization
  • Fig. 68 Market Share of Key Market Players- Blood Glucose Monitoring Devices Market
目次
Product Code: GVR-3-68038-688-2

Blood Glucose Monitoring Devices Market Growth & Trends:

The global blood glucose monitoring devices market size is expected to reach USD 23.21 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.25% from 2024 to 2030. Patients with diabetes and their healthcare professionals benefit significantly from Blood Glucose Monitoring Devices (BGMD). BGMD is becoming more widely accepted as an important component of intensive diabetic treatment. It allows diabetic patients to measure their blood sugar levels within minutes with ease and convenience wherever they are. The continuous glucose monitoring (CGM) devices help analyze the blood glucose level continuously and in real-time. It also helps patients determine the level of dietary intake and dosage of insulin. In addition, factors such as sedentary lifestyles including consumption of junk food, alcohol, and smoking, and a surge in the need for safer and faster diagnoses are expected to boost the market growth during the forecast period.

According to the International Diabetes Federation (IDF), the total number of diabetic patients is expected to expand to 643 million (11.3 %) by 2030 and 783 million (12.2 %) by 2045. Obesity is one of the major factors propelling the prevalence of diabetes. Obese individuals are up to 80 times more likely than non-obese persons to develop diabetes. Studies suggest that 650 million people over the age of 18 are obese. Further, due to the ongoing efforts by the government and healthcare organizations such as the International Diabetes Federation (IDF) to control diabetes, the market is likely to rise at a rapid pace throughout the forecast period. Through a network of stakeholders and collaborators, these organizations provide needed expertise and support diabetes awareness campaigns. Rising health-care funding is also expected to boost market growth.

Blood Glucose Monitoring Devices Market Report Highlights:

  • North America held the largest revenue share in 2023 owing to favorable reimbursement policies, local presence of key players, and supportive government initiatives
  • Based on product, the self-monitoring devices segment held the largest revenue share of 66.37% in 2023 and is expected to grow at a significant pace over the forecast period
  • The continuous blood glucose monitoring devices product segment is expected to be the fastest-growing segment during the forecast period
  • In the self-monitoring devices, the testing strips segment accounted for the largest revenue share in 2023 owing to the high usage of these strips and affordability.
  • By end-use, the home care segment is expected to grow at a rapid pace during the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Primary Sources
  • 1.11. List of Abbreviations

Chapter 2. Blood Glucose Monitoring Devices Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Products and End Use Snapshots
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Blood Glucose Monitoring Devices Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising geriatric population worldwide
    • 3.4.2. Increasing number of diabetes patients
    • 3.4.3. Increasing awareness about diabetes preventive care
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of devices
  • 3.6. Blood Glucose Monitoring Devices Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier Power
      • 3.6.1.2. Buyer Power
      • 3.6.1.3. Substitution Threat
      • 3.6.1.4. Threat Of New Entrant
      • 3.6.1.5. Competitive Rivalry
    • 3.6.2. PESTLE Analysis
      • 3.6.2.1. Political Landscape
      • 3.6.2.2. Technological Landscape
      • 3.6.2.3. Economic Landscape
    • 3.6.3. Pricing Analysis

Chapter 4. Blood Glucose Monitoring Devices: Product Estimates & Trend Analysis

  • 4.1. Global Blood Glucose Monitoring Market: Product Segment Dashboard
  • 4.2. Global Blood Glucose Monitoring Devices Market by Product Outlook
  • 4.3. Global Blood Glucose Monitoring Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Self-Monitoring Devices
    • 4.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 4.4.2. Blood Glucose Meter
      • 4.4.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 4.4.3. Testing Strips
      • 4.4.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 4.4.4. Lancets
      • 4.4.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 4.5. Continuous Blood Glucose Monitoring Devices
    • 4.5.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 4.5.2. Sensors
      • 4.5.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 4.5.3. Transmitter & Receiver
      • 4.5.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 4.5.4. Insulin Pumps
      • 4.5.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)

Chapter 5. Blood Glucose Monitoring Devices: End-use Estimates & Trend Analysis

  • 5.1. Global Blood Glucose Monitoring Market: End-use Segment Dashboard
  • 5.2. Global Blood Glucose Monitoring Market: End-use Movement Analysis
  • 5.3. Global Blood Glucose Monitoring Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.5. Homecare
    • 5.5.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.6. Diagnostics Centers
    • 5.6.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Global Regional Market Snapshot
  • 6.3. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key Country Dynamics
      • 6.4.1.2. Competitive Scenario
      • 6.4.1.3. Regulatory Framework
      • 6.4.1.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Canada Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Competitive Scenario
      • 6.5.1.3. Regulatory Framework
      • 6.5.1.4. UK Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Germany Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.5.3. Spain
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Spain Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. France Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Italy Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Denmark Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 6.5.6.5.
    • 6.5.7. Sweden
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Sweden Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Norway Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Competitive Scenario
      • 6.6.1.3. Regulatory Framework
      • 6.6.1.4. Japan Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. China Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. India Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.6.4. South Korea
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. South Korea Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.6.5. Thailand
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Thailand Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Australia Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory Framework
      • 6.7.1.4. Brazil Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.7.2. Mexico
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Mexico Blood Glucose Monitoring Devices Market, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Argentina Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Competitive Scenario
      • 6.8.1.3. Regulatory Framework
      • 6.8.1.4. South Africa Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Saudi Arabia Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. UAE Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Kuwait Market Estimates and Forecasts 2018 To 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company /Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List Of Key Distributors and Channel Partners
    • 7.3.2. Key Customers
    • 7.3.3. Key Company Market Share Analysis, 2023
    • 7.3.4. Abbott
      • 7.3.4.1. Overview
      • 7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Medtronic plc
      • 7.3.5.1. Overview
      • 7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. F. Hoffmann-La Roche Ltd
      • 7.3.6.1. Overview
      • 7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Ascensia Diabetes Care Holdings AG
      • 7.3.7.1. Overview
      • 7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. LifeScan IP Holdings, LLC
      • 7.3.8.1. Overview
      • 7.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Dexcom, Inc
      • 7.3.9.1. Overview
      • 7.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. SANOFI
      • 7.3.10.1. Overview
      • 7.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.10.3. Product Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. Lilly (Elly Lilly and Company)
      • 7.3.11.1. Overview
      • 7.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.11.3. Product Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. B Braun SE
      • 7.3.12.1. Overview
      • 7.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.12.3. Product Benchmarking
      • 7.3.12.4. Strategic Initiatives